| scholarly article | Q13442814 |
| P50 | author | Mordechai Muszkat | Q43141188 |
| Mika Scheinin | Q60732950 | ||
| Chun Li | Q64183498 | ||
| Alastair S. Wood | Q80142712 | ||
| Daniel Kurnik | Q85342261 | ||
| Gbenga G Sofowora | Q117270558 | ||
| P2093 | author name string | C Michael Stein | |
| Eitan A Friedman | |||
| P2860 | cites work | An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling | Q24290107 |
| Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes | Q24336126 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| The effects of increasing plasma concentrations of dexmedetomidine in humans | Q28141747 | ||
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | Q28270700 | ||
| Genome-wide association study identifies eight loci associated with blood pressure | Q29614414 | ||
| Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array | Q33475633 | ||
| Leveraging genetic variability across populations for the identification of causal variants. | Q33571814 | ||
| Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. | Q33625202 | ||
| Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission | Q33887636 | ||
| Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene | Q34375677 | ||
| Complex haplotypes derived from noncoding polymorphisms of the intronless alpha2A-adrenergic gene diversify receptor expression | Q34600291 | ||
| Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists | Q34674600 | ||
| Alpha2-adrenoceptor subtypes--unexpected functions for receptors and ligands derived from gene-targeted mouse models. | Q36896725 | ||
| Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. | Q37375138 | ||
| Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. | Q41675919 | ||
| Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks | Q41676928 | ||
| The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization | Q43756517 | ||
| Simultaneous quantitation of dexmedetomidine and glucuronide metabolites (G-Dex-1 and G-Dex-2) in human plasma utilizing liquid chromatography with tandem mass spectrometric detection | Q44999526 | ||
| Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans | Q45030653 | ||
| Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine | Q46741321 | ||
| Variations in the alpha2A-adrenergic receptor gene and their functional effects. | Q46972798 | ||
| Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype | Q48111063 | ||
| Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. | Q53514987 | ||
| Optimization of high-performance liquid chromatographic assay for catecholamines. Determination of optimal mobile phase composition and elimination of species-dependent differences in extraction recovery of 3,4-dihydroxybenzylamine | Q68184917 | ||
| Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype | Q71104692 | ||
| Functional correlates of alpha(2A)-adrenoceptor gene polymorphism in the HANE study | Q73114914 | ||
| SNP genotyping by the 5'-nuclease reaction | Q78689385 | ||
| Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks? | Q83195219 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dexmedetomidine | Q412133 |
| P304 | page(s) | 179-187 | |
| P577 | publication date | 2011-02-15 | |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine | |
| P478 | volume | 4 |
| Q41127855 | ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer |
| Q36004385 | Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction |
| Q33753508 | Alpha2A-adrenergic receptor and eNOS genetic polymorphisms are associated with exercise muscle vasodilatation in apparently healthy individuals |
| Q36408110 | Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population |
| Q33844872 | Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes |
| Q26994769 | Interpatient variability in dexmedetomidine response: a survey of the literature |
| Q92554978 | Relationship between genetic variation in the α2A-adrenergic receptor and the cardiovascular effects of dexmedetomidine in the Chinese Han population |
| Q100381629 | Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial |
| Q37209353 | Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose. |
Search more.